U.S. federal trademark · Serial No. 97599568 · Reg. No. UK00003831277
Biopharmaceuticals and medicines in the form of cell suspension for IV infusion for cell and gene therapy during cancer treatment; biopharmaceuticals and medicines in the form of cell suspension for IV infusion for the treatment of cancer
Medical services; medical treatment services in the nature of providing personalized medicine to patients during the treatment of cancer; medical services in the nature of providing medical treatment through the provision of cell and gene therapy medicines and therapeutics; medical treatment services, namely, medical treatment of cancer by delivering cell and gene therapy medicines via IV infusion
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.